# A community health nurse is conducting a health promotion assessment for a 45-year-old client during a routine wellness visit. Which assessment finding would be the MOST important priority for immediate follow-up and intervention?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=543677  
> language: ko  
> subject: Next Gen NCLEX

## 문제

A community health nurse is conducting a health promotion assessment for a 45-year-old client during a routine wellness visit. Which assessment finding would be the MOST important priority for immediate follow-up and intervention?

## 보기

1. Blood pressure reading of 138/88 mmHg on two separate occasions
2. Waist circumference of 42 inches with BMI of 32 kg/m² **✔ 정답**
3. Total cholesterol level of 210 mg/dL with HDL of 45 mg/dL
4. Fasting blood glucose level of 108 mg/dL

**정답: 2**

## 해설

Central obesity (waist circumference 42 inches, BMI 32) is the highest priority due to its strong association with metabolic syndrome and cardiovascular risks. Other findings represent lower-risk or manageable conditions.

## 심화 해설

Clinical Reasoning and Priority Setting

The most important priority for immediate follow-up is the client's central obesity, indicated by a waist circumference of 42 inches and a BMI of 32 kg/m². While the other findings represent cardiovascular risk factors that require management, this specific combination signals a significantly higher and more immediate risk for adverse outcomes, including recurrent cardiovascular events and progression to multimorbidity, based on the current evidence.

The rationale for prioritizing central obesity over the other findings is rooted in how fat distribution, rather than just total body weight, drives disease risk. The provided evidence reframes obesity as a condition where adiposity indices that capture central fat are superior predictors of poor health trajectories. A waist circumference of 42 inches in a male (or >35 inches in a female) is a clinical marker of visceral adiposity, which is metabolically active and directly contributes to systemic inflammation, insulin resistance, and atherosclerosis. Study [1] demonstrates that in patients with established cardiovascular disease, indices of central obesity are differentially associated with recurrent cardiovascular events, highlighting that location of fat is a critical prognostic factor beyond total body mass. This makes the finding an immediate threat that can accelerate damage across multiple organ systems.

Furthermore, this client's profile aligns with the highest-risk phenotype described in the updated obesity frameworks. Study [2] validates a stratification model where individuals with elevated BMI and central adiposity face the greatest risk for mortality and cardiovascular outcomes. The client’s BMI of 32 kg/m² places them in class I obesity, but the addition of a high waist circumference reclassifies them into a high-risk category that demands urgent, targeted intervention. This is not simply a matter of weight management; it is about interrupting a potent disease driver. Study [3] reinforces this by showing that combining BMI with measures of fat distribution, like waist-to-height ratio, is superior for predicting the trajectory from a single condition to multimorbidity (the development of two or more chronic conditions). The other findings—mildly elevated blood pressure, borderline cholesterol, and impaired fasting glucose—are often the initial clinical manifestations of the underlying metabolic dysfunction driven by this central obesity. Addressing the root cause takes clinical priority to prevent the cascade of new diagnoses [3].References (research sources)

- [1]Central Obesity and Recurrent Cardiovascular Events in Patients With Obstructive Sleep Apnea: The SAVE Study.Research articleYou S, Zheng D, Loffler KA, McEvoy RD, Li Q, Han Q, Barbé F, Liu CF, Cao Y, Wang X, Lorenzi-Filho G, Tripathi M, Anderson C, as the SAVE Investigators. (2026) · DOI: 10.1212/wnl.0000000000218334

- [2]Redefining Obesity and Risk: Extending the 2024 European Association for the Study of Obesity Framework with Morbidity Stratification in the UK Biobank.Research articleTan M, Tang X, Nan W, Peng Z, Xing Z. (2026) · DOI: 10.1159/000552804

- [3]Classification and Severity Assessment of Obesity in Clinical Risk Prediction of Multimorbidity Trajectories.Research articleAmpadu-Yeboah A, Carr A, Ho F, Gill J, Sattar N, Jani BD. (2026) · DOI: 10.1111/cob.70097

## 임상 시나리오

Clinical Priority: Central ObesityWhy Waist Circumference Trumps Other Risk Factors
A waist circumference of 42 inches with a BMI of 32 kg/m² signals visceral adiposity, a metabolically active state driving systemic inflammation and insulin resistance. This poses a more immediate threat for recurrent cardiovascular events than isolated hypertension or dyslipidemia.

In community health assessments, prioritize findings based on the potential for immediate adverse outcomes. Central obesity is a core component of metabolic syndrome and a stronger predictor of disease progression than BMI alone. Intervention should focus on aggressive lifestyle modification and pharmacological management to reduce waist circumference.

CautionDo not delay intervention for central obesity while addressing other risk factors. The combination of high waist circumference and elevated BMI indicates a high-risk phenotype requiring immediate, intensive follow-up to prevent progression to multimorbidity.

## 핵심 개념

- **Central Obesity** — Excess fat accumulation in the abdominal area, specifically visceral fat, defined by a waist circumference >40 inches in men and >35 inches in women.
- **Visceral Adiposity** — Metabolically active fat stored within the abdominal cavity around internal organs, which promotes systemic inflammation, insulin resistance, and atherosclerosis.
- **Body Mass Index (BMI)** — A screening measure calculated as weight in kilograms divided by height in meters squared; a BMI of 30 kg/m² or greater is classified as obesity.
- **Metabolic Syndrome** — A cluster of conditions including central obesity, hypertension, dyslipidemia, and insulin resistance that synergistically increase the risk for heart disease, stroke, and type 2 diabetes.
- **Priority Setting** — A clinical decision-making process using principles like Maslow's hierarchy or the ABCs (Airway, Breathing, Circulation) to determine which patient problem poses the greatest immediate threat and requires intervention first.

## 같은 주제 문제

- [A community health nurse is developing a health promotion program for a group of middle-ag…](https://mymerci.kr/pages/nclex_q.php?qn_id=543670)
- [A public health nurse is implementing a chronic disease management initiative for a divers…](https://mymerci.kr/pages/nclex_q.php?qn_id=543671)
- [A community health nurse is developing a health promotion program for a diverse urban comm…](https://mymerci.kr/pages/nclex_q.php?qn_id=543672)
- [A school nurse is designing a wellness initiative for high school students in a low-income…](https://mymerci.kr/pages/nclex_q.php?qn_id=543673)
- [A community health nurse is developing a health promotion program for a group of middle-ag…](https://mymerci.kr/pages/nclex_q.php?qn_id=543674)
- [A community health nurse is conducting a health promotion assessment for a 45-year-old cli…](https://mymerci.kr/pages/nclex_q.php?qn_id=543675)
- [A community health nurse is conducting a health promotion screening at a senior center. Wh…](https://mymerci.kr/pages/nclex_q.php?qn_id=543676)
- [A school nurse is conducting a health screening for a 50-year-old teacher during a routine…](https://mymerci.kr/pages/nclex_q.php?qn_id=543678)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._